Pharmaceutical formulations: salts of...

Details Pharmaceutical formulations: salts of... Pharmaceutical formulations: salts of...

2011-07-19

2011-07-19

Henley, III, Raymond J (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S016000, C546S019000

Reexamination Certificate

active

07981905

ABSTRACT:
Pharmaceutical formulations containing salts of (5S,8S)-8-[{(1R)-1-(3,5-Bis-(trifluoromethyl)phenyl]-ethoxy}-methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one, represented by Formula I, are disclosed. Disclosed also are methods of treatment utilizing such dosage forms.

REFERENCES:
patent: 6499984 (2002-12-01), Ghebre-Sellassie et al.
patent: 2003/0158173 (2003-08-01), Paliwal et al.
patent: 2005/0131011 (2005-06-01), Stupple
patent: WO96/26726 (1996-09-01), None
patent: WO03/051840 (2003-06-01), None
patent: WO2005/063243 (2005-07-01), None
International Search Report, PCT/US2007/008345; mailed Jan. 22, 2008; 4 pages.
Noory, et. al. Steps for Development of a Dissolution Test for Sparingly Water Soluble Drug Products, Dissolution Technologies, Feb. 2000 Article 3.
Reddy, et. al. Novel Neurokinin-1 antagonist as antiemetics for the treatment of chemotherapy-induced emesis, Supportive Cancer Therapy, Apr. 1, 2006:3(3):140-2.
Miaskkowski et. al. Cancer Pain, Nov. 2005.

Affiliated with

Also associated with

Rating

Pharmaceutical formulations: salts of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations: salts of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations: salts of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2693979